Current Events in November 2024

Browse Current Events by year

2024

Browse Current Events by month

Get trending consumer news and recalls

    By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

    Thanks for subscribing.

    You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

    Get trending consumer news and recalls

      By entering your email, you agree to sign up for consumer news, tips and giveaways from ConsumerAffairs. Unsubscribe at any time.

      Thanks for subscribing.

      You have successfully subscribed to our newsletter! Enjoy reading our tips and recommendations.

      Ozempic may affect muscle mass, new study finds

      Experts say significant weight loss can greatly affect the muscles

      As more and more consumers utilize Ozempic and related drugs to help them lose weight, many may be skeptical or concerned about the potential side effects. 

      A recent study conducted by researchers at the University of Alberta, McMaster University, and the Pennington Biomedical Research Center are uncovering another potential side effect of the weight loss drug – loss of muscle mass. 

      According to the researchers, any significant weight loss can have this effect on the muscles. However, it’s an important thing for consumers to keep in mind as they embark on their health and wellness journeys. 

      “We have to be mindful of the side effects that we are seeing with the new weight loss medications, such as a person eating less while on the medications and not getting the appropriate amount of dietary vitamins and minerals,” said researcher Dr. Steven Heymsfield. 

      “Also, when a person loses weight, they are not only losing fat, they also lose muscle. We are looking at how that muscle loss can be better managed with consumption of an adequate amount of protein along with an optimum amount of exercise.” 

      Rapid weight loss could lead to rapid loss of muscle mass

      In this study, the researchers looked at earlier work that analyzed the effect of weight loss from Ozempic and other similar drugs and the loss of muscle mass. 

      The team explained that the loss of muscle mass is measured in fat-free mass. When patients take Ozempic or other similar weight loss drugs, their fat-free mass can range anywhere between 25-39% of total weight lost over 32-76 weeks. 

      Comparatively, when consumers lose weight without the assistance of drugs like Ozempic, the loss of muscle mass isn’t as significant. The loss of muscle mass in these cases typically ranges from 10-30%. 

      Additionally, the researchers learned that the muscle mass lost from using Ozempic over long periods of time is greater than typical age-related muscle mass loss that happens naturally as consumers get older. 

      Risks of muscle mass loss

      While the researchers explain that this loss of muscle mass is likely the result of the speed with which consumers have lost a significant amount of weight, and not the drug itself, it’s still an important component of overall health and wellness. 

      Some of the health risks of muscle mass loss include: 

      • More frequent falls

      • Loss of mobility, strength, flexibility

      • Heart health risks

      • Life expectancy

      • Higher risk of infection

      • Poorer insulin resistance

      “Dismissing the importance of muscle loss can create a disconnect between patients' increased awareness of muscle and the role it plays in health, and clinicians who downplay these concerns, affecting adherence to and the development of optimized treatment plans,” the researchers wrote.

      As more and more consumers utilize Ozempic and related drugs to help them lose weight, many may be skeptical or concerned about the potential side effects....

      Compounded Ozempic, Wegovy may be dangerous

      Ten deaths and 100 hospitalizations reported

      Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 hospitalizations and 10 deaths.

      CEO Lars Fruergaard Jorgensen expressed concern, stating that only Novo Nordisk makes real semaglutide and does not supply it to others.

      “Honestly, I’m quite alarmed by what we see in the US now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN. “Patients who believe that they’re getting access to a safe product, and they believe they’re getting semaglutide … I know for a fact that they are not getting semaglutide, because there’s only one semaglutide, and that’s produced by Novo Nordisk, and we don’t sell that to others.”

      Compounded drugs, created by other pharmacies when there’s a shortage, are not FDA-approved and may carry risks. The FDA’s database includes reports of adverse effects with compounded semaglutide, including dosing errors and cases involving a salt form of the drug that differs from the approved version.

      Semaglutide is still on the FDA’s shortage list, though Novo Nordisk is working to resolve it. The FDA is evaluating supply and demand and monitoring for patient safety.

      About semaglutide

      Semaglutide is a medication that mimics the glucagon-like peptide-1 (GLP-1) hormone, which plays a crucial role in regulating blood sugar levels and appetite. It is marketed under brand names such as Ozempic, Wegovy, and Rybelsus, each approved for specific uses:

      • Ozempic: Approved for managing type 2 diabetes and reducing the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease.

      • Wegovy: Approved for chronic weight management in adults with obesity or overweight conditions, in conjunction with a reduced-calorie diet and increased physical activity.

      • Rybelsus: An oral form of semaglutide approved for improving blood sugar control in adults with type 2 diabetes.

      Reasons for Semaglutide's Popularity:

      1. Effective Weight Loss: Clinical trials have demonstrated that semaglutide can lead to significant weight loss, making it a popular choice for individuals seeking to manage obesity.

      2. Improved Blood Sugar Control: For patients with type 2 diabetes, semaglutide effectively lowers blood sugar levels, aiding in disease management.

      3. Cardiovascular Benefits: Semaglutide has been shown to reduce the risk of major cardiovascular events, such as heart attack and stroke, in individuals with type 2 diabetes and existing heart disease.

      4. Convenient Dosing Options: Available in both injectable (once-weekly) and oral (daily) forms, semaglutide offers flexibility to suit patient preferences.

      5. Broader Health Benefits: Emerging research suggests potential benefits of semaglutide in reducing risks of conditions like colorectal cancer and kidney disease, further enhancing its appeal.

      While semaglutide offers numerous benefits, it's important to be aware of potential side effects, including gastrointestinal issues and, in rare cases, more serious adverse effects. Consulting with a healthcare provider is essential to determine if semaglutide is appropriate for individual health needs.

      Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 h...